Tevogen Bio Holdings Inc.
News
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
Globe Newswire WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ( Tevogen or Tevogen Bio ) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...\n more…
CORRECTION Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company's Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
Globe Newswire WARREN, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Tevogen Bio Inc (Nasdaq: TVGN), please note that paragraph two has been updated. The...\n more…
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company's Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
Globe Newswire WARREN, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ( Tevogen or Tevogen Bio ) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...\n more…
Tevogen Bio's Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health
Globe Newswire WARREN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. ( Tevogen or Tevogen Bio ) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...\n more…
Tevogen Bio's Founding CEO, Ryan Saadi, Expresses Conviction in Company's Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilu
Globe Newswire WARREN, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ( Tevogen or Tevogen Bio ) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...\n more…
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
Globe Newswire WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. ( Tevogen or Tevogen Bio ) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...\n more…